Literature DB >> 10906083

Progression of eye disease in "cured" leprosy patients: implications for understanding the pathophysiology of ocular disease and for addressing eyecare needs.

S Lewallen1, N C Tungpakorn, S H Kim, P Courtright.   

Abstract

BACKGROUND: Ocular damage in leprosy is due either to nerve damage or infiltration by mycobacteria. There is currently little information about the magnitude and nature of incident ocular pathology in cured leprosy patients. This information would increase our understanding of the pathophysiology of ocular involvement in leprosy and help in developing programmes to address the eyecare needs of leprosy patients who have been released from treatment. The cumulative incidence of leprosy related ocular pathology and cataract was measured during an 11 year follow up period in cured leprosy patients released from treatment in Korea.
METHODS: In 1988 standardised eye examinations were performed on 501 patients in eight resettlement villages in central South Korea. In May 1999 standardised eye examinations were repeated in this population.
RESULTS: Among the patients in whom there was no sight threatening leprosy related ocular disease (lagophthalmos, posterior synechia, or keratitis) in 1988, 14.7% developed one or more of these conditions. Overall, among those with no vision reducing cataract in 1988, 26.4% had developed a vision reducing lens opacity in at least one eye. Among patients examined in both 1988 and 1999, 14.3% developed visual impairment and 5.7% developed blindness.
CONCLUSION: This study demonstrates that leprosy related ocular pathology progresses in some patients even after they are cured mycobiologically. The progressive leprosy related lesions are the result of chronic nerve damage; ocular lesions due to infiltration by Mycobacterium leprae did not develop. Based on the factors found to be associated with development of the most visually significant findings (posterior synechia, keratitis, and cataract) certain patients should be targeted at discharge for active follow up eye care. We suggest that patients with lagophthalmos (even in gentle closure), trichiasis, small pupils, and posterior synechiae should be screened regularly for the development of lagophthalmos in forced closure, keratitis, and cataract.

Entities:  

Mesh:

Year:  2000        PMID: 10906083      PMCID: PMC1723588          DOI: 10.1136/bjo.84.8.817

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Training for primary eye care in leprosy.

Authors:  P Courtright; H S Lee; S Lewallen
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Ocular autonomic dysfunction and intraocular pressure in leprosy.

Authors:  S Lewallen; P Courtright; H S Lee
Journal:  Br J Ophthalmol       Date:  1989-12       Impact factor: 4.638

3.  Excess mortality associated with blindness in leprosy patients in Korea.

Authors:  P Courtright; S H Kim; H S Lee; S Lewallen
Journal:  Lepr Rev       Date:  1997-12       Impact factor: 0.537

4.  Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda.

Authors:  K M Waddell; P R Saunderson
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

5.  Eyelid changes in long-standing leprosy.

Authors:  F C Guimarães; A A Cruz
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1998-07       Impact factor: 1.746

6.  Progression of eye lesions in leprosy: ten-year follow-up study in The Netherlands.

Authors:  M Hogeweg; W R Faber
Journal:  Int J Lepr Other Mycobact Dis       Date:  1991-09

7.  Comparison of the old and new W.H.O. leprosy disability grading scheme for ocular disabilities.

Authors:  P Courtright; S Lewallen; H S Lee
Journal:  Int Ophthalmol       Date:  1991-09       Impact factor: 2.031

  7 in total
  11 in total

1.  Arthritis, progressive maculopapular rash and severe peripheral neuropathy in a 60-year-old man. Diagnosis: Leprosy.

Authors:  François Tremblay; Martin Albert
Journal:  CMAJ       Date:  2013-12-23       Impact factor: 8.262

2.  Prevalence and causes of blindness and low vision in leprosy villages of north eastern Nigeria.

Authors:  C Mpyet; A W Solomon
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

3.  Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea.

Authors:  P Courtright; S Lewallen; N Tungpakorn; B H Cho; Y K Lim; H J Lee; S H Kim
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

4.  Ocular complications of leprosy in yemen.

Authors:  Raga A A Salem
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

5.  The prevalence of ocular complications in leprosy patients seen in the United Kingdom over a period of 21 years.

Authors:  A N J Malik; R W Morris; T J Ffytche
Journal:  Eye (Lond)       Date:  2011-03-18       Impact factor: 3.775

6.  Peripheral Neuropathy Due to Leprosy.

Authors:  Sharon P. Nations; Richard J. Barohn
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.972

7.  Evaluation of the cutaneous sensation of the face in patients with different clinical forms of leprosy.

Authors:  Marlice Fernandes de Oliveira; Douglas Eulálio Antunes; Diogo Fernandes Dos Santos; Isabela Maria Bernardes Goulart
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

8.  Bilateral corneal perforation caused by neurotrophic keratopathy associated with leprosy: a case report.

Authors:  Satoshi Iraha; Shoko Kondo; Takefumi Yamaguchi; Toshihiro Inoue
Journal:  BMC Ophthalmol       Date:  2022-01-29       Impact factor: 2.209

Review 9.  Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1.

Authors:  Joel Carlos Lastória; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

10.  The Lateral Tarsal Strip for Paralytic Ectropion in Patients with Leprosy.

Authors:  Mihn-Sook Jue; Jisook Yoo; Min-Soo Kim; Hyang-Joon Park
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.